Multi Dimensional System for Evaluating a Preventive Program for Upper Extremity Disorders Among Computer Operators

March 22, 2012 updated by: Medical Corps, Israel Defense Force

Computer settings points to a number of risk factors which may induce the development of Work related MSD (WRMSD). In light of the expanded use of computers and the increased occurrence of Upper Extremity (UE) WRMSD among computer operators various intervention programs have been developed and tested. Nevertheless, many of these programs do not meet the criteria of quality and level of evidence.

The main objective of this study is to use simultaneously a three dimensional (3D) kinematic analysis system, surface electromyography (SEMG) and fingertip force measurement system (Flexiforce) while typing, to test the efficacy of primary and secondary preventive intervention programs aimed at reducing MSD among computer operators.

Work hypothesis: Significant score differences will be found on the evaluation parameters between the research group which underwent ergonomic training with biofeedback, the group without feedback, and the control group.The evaluated parameters will correlate with the appearance of MSD symptoms and pain and will affect level of function.

The study will include 66 participants, programmers and computer engineers. The participants will be assigned randomly to one of three groups: 1) participants will receive ergonomic training with biofeedback; 2) participants will receive ergonomic training without biofeedback; and 3) control group, without intervention. Each group will consist of 22 participants.

Treatment efficacy will be tested both at work and in the motion lab. In the lab, 3D kinematic measurements and fingertip forces relevant to typing while entering a standard text will be measured. At the work site, anthropometric and measurements, work station measurements, posture observation and questionnaires about, psychosocial status, function and pain level will be filled The preventive program will be performed at the workstation after the preliminary data collection phase. The program will consist of one group meeting at the workplace for all employees participating in the study, and individual instruction at the workstation, including 3-6 meetings for the two research groups. Data will be collected before and after the intervention program.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ramat Gan, Israel
        • Recruiting
        • Motion Laboratory, Sheba medical center
        • Principal Investigator:
          • Uri givon, MD
        • Contact:
        • Principal Investigator:
          • Ron Frimer, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • subjects working more than four hours per day in front of a computer and are right-hand dominant.
  • Healthy or suffering from diagnoses of UE-MSD. (e.g. Rotator cuff syndrome , Lateral epicondylitis, Cubital tunnel syndrome, Carpal tunnel syndrome, Flexor-extensor peri-tendinitis or teno-synovitis of the forearm-wrist region, De Quervain's disease and Nonspecific MSD

Exclusion Criteria:

  • Participants suffering from orthopedic injury or neurological deficit (with the exception of the diagnosis mentioned above).
  • Medical conditions that cause swelling of the joints or hand numbness (pregnancy, diabetes, heart condition, arthritis).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ergonomic consulting
Ergonomic consulting without biofeedback
Standard ergonomic intervention , how to sit and work with computers
Other Names:
  • intervention no 1
Experimental: Ergonomic consulting with biofeedback
Ergonomic intervention with biofeedback
Ergonomic intervention, how to sit and work, an d muscle re education with a SurfaceElrctromyograph Biofeedback (SEMG biofeedback)
Other Names:
  • intervention no.2
No Intervention: general instructions
general instructions with no intervention
general instructions no intervention
Other Names:
  • intervention 3

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Musculoskeletal disorders measurement (MSD score)
Time Frame: Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.
The MSD score of the whole body will be collected out of a self administrated questionnaire in the first meeting before intervention and in the last meeting. the score indicates the number of painful body regions that were harmful in the last week before answering the Questionnaire. Negative differences between post and pre intervention will indicate improvement in pain.
Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rapid Upper Limb Assessment (RULA)score
Time Frame: Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one
The RULA is an observation that assess the posture at work. The assessment will be held in the work place in the first meeting before intervention and in the last meeting. The score ranged between 0-7, higher score indicates higher risk for MSD. Negative differences between post and pre intervention will indicate improvement in posture at work.
Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one
Kinematic Data [range of motion ( R.O.M) and angular velocity]measured by 3D motion analysis system.
Time Frame: Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.
The Kinematics of the upper extremity (fingers, wrist and elbow) will be measured in the second and in the last meeting at the motion laboratory. The second meeting will be not more than 2 weeks after the first meeting.R.O.M will be measured in degrees and the angular velocity will be presented in degrees per seconds. .Negative differences between post and pre intervention indicates improvement in R.O.M and angular velocity.
Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.
Muscle activity
Time Frame: Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.
The muscle activity amplitude of the wrist and finger extensors and the upper trapezius will be measured and collected in the second meeting at the motion laboratory simultaneously with the kinematic data.The muscle amplitude will be presented as percentile of the Maximal Voluntary Contraction (MVC) of the same muscles. Higher percentage of muscle activity will indicate higher muscle load. Negative differences between post and pre intervention indicates improvement in muscle activity.
Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.
Psychosocial job characteristics assessment (DCSQ)
Time Frame: Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.
The D.C.S.Q will be measured by a self administrated questionnaire in the first meeting before intervention and in the last meeting. The job demands score range between 5-25 and the decision latitude score range between 8-40. Low level of job demands and high decision latitude indicates low level of stress at work.
Minimum 10 weeks and maximum 15 weeks between the first measurement and the last one.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Yafi Levanon, MsC, Sheba Medical Center , Tel aviv University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Anticipated)

March 1, 2012

Study Completion (Anticipated)

February 1, 2013

Study Registration Dates

First Submitted

July 14, 2011

First Submitted That Met QC Criteria

March 22, 2012

First Posted (Estimate)

March 23, 2012

Study Record Updates

Last Update Posted (Estimate)

March 23, 2012

Last Update Submitted That Met QC Criteria

March 22, 2012

Last Verified

March 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 757-2008-IDF-CTIL

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Disorders

Clinical Trials on Standard ergonomic intervention

Subscribe